Skip to content

Osteophil Beta-TCP

by Cytophil, Inc.

510(k) K102937

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK102937 Date27 Dec 2010ClearedStatusActive

Official records

From the FDA record

Received by the FDA
4 Oct 2010
FDA decision
27 Dec 2010 (Substantially Equivalent)
FDA review time
84 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K102937 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MQV
Device class
Class II
Regulation
21 CFR Part 888.3045
Advisory committee
Orthopedic
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Osteophil Beta-TCP is a porous, synthetic, resorbable bone void filler classified as a bone graft substitute. It is composed of beta-Tricalcium Phosphate (B-TCP) and designed to mimic the structure of human cancellous bone through a multidirectional interconnected porosity. This device is intended for filling bony defects in orthopedic applications, including the extremities, posterolateral spine, and pelvis. Its primary function is to provide structural support and promote bone regeneration in surgical sites.

The device is supplied as granules in sizes ranging from 1 mm to 4 mm and is implanted directly by surgeons into the target defect site. Osteophil Beta-TCP is a single-use, non-sterile product, as indicated by its FDA 510(k) clearance (K102937) under product code MQV. It is regulated as a Class II medical device under the Orthopedic advisory committee and is intended for use in orthopedic procedures. Storage and handling must comply with standard medical device protocols for bone graft substitutes.

Devices cleared under K102937

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K102937
UDI-DISize and differences
Zavation 02-030-03-ZVG
ZAVATION
02-030-03-ZVG00842166115484 —On the market

Similar devices

Other devices filed under FDA product code MQV (Filler, Bone Void, Calcium Compound).

Other devices from Cytophil, Inc

See all devices from Cytophil, Inc →